Beese Fulmer Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.65M Sell
30,114
-2,862
-9% -$330K 0.23% 79
2025
Q4
$3.5M Sell
32,976
-121,911
-79% -$11.4M 0.23% 82
2025
Q3
$13M Sell
154,887
-12,251
-7% -$1.01M 0.9% 38
2025
Q2
$13.2M Buy
167,138
+4,375
+3% +$348K 0.99% 35
2025
Q1
$14.6M Buy
162,763
+920
+0.6% +$85.9K 1.26% 27
2024
Q4
$16.1M Buy
161,843
+1,266
+0.8% +$131K 1.37% 20
2024
Q3
$18.2M Buy
160,577
+2,058
+1% +$245K 1.57% 19
2024
Q2
$19.6M Buy
158,519
+3,355
+2% +$432K 1.79% 14
2024
Q1
$20.5M Sell
155,164
-378
-0.2% -$46.6K 1.93% 12
2023
Q4
$17M Buy
155,542
+54,212
+54% +$5.63M 1.76% 13
2023
Q3
$10.4M Buy
101,330
+689
+0.7% +$74.3K 1.18% 29
2023
Q2
$11.6M Buy
100,641
+3,830
+4% +$435K 1.26% 27
2023
Q1
$10.3M Buy
96,811
+1,263
+1% +$136K 1.18% 28
2022
Q4
$10.6M Buy
95,548
+4,949
+5% +$506K 1.28% 25
2022
Q3
$7.8M Buy
90,599
+1,797
+2% +$160K 1.05% 32
2022
Q2
$8.1M Buy
88,802
+964
+1% +$85.5K 1.04% 34
2022
Q1
$7.21M Sell
87,838
-951
-1% -$75K 0.78% 46
2021
Q4
$6.8M Buy
88,789
+1,597
+2% +$127K 0.71% 48
2021
Q3
$6.55M Buy
87,192
+1,529
+2% +$116K 0.74% 48
2021
Q2
$6.66M Sell
85,663
-4,383
-5% -$326K 0.75% 46
2021
Q1
$6.62M Buy
90,046
+10,250
+13% +$756K 0.8% 46
2020
Q4
$6.23M Buy
79,796
+3,755
+5% +$287K 0.8% 44
2020
Q3
$6.02M Sell
76,041
-2,179
-3% -$171K 0.85% 41
2020
Q2
$5.77M Sell
78,220
-4,990
-6% -$376K 0.85% 43
2020
Q1
$6.11M Buy
83,210
+297
+0.4% +$23.3K 1.08% 28
2019
Q4
$7.2M Buy
82,913
+3,572
+5% +$293K 1.01% 33
2019
Q3
$6.37M Buy
79,341
+16,628
+27% +$1.33M 0.96% 37
2019
Q2
$5.02M Sell
62,713
-530
-0.8% -$40.6K 0.95% 42
2019
Q1
$5.02M Buy
63,243
+231
+0.4% +$17.3K 0.99% 43
2018
Q4
$4.59M Sell
63,012
-44
-0.1% -$3.11K 1.03% 40
2018
Q3
$4.27M Buy
63,056
+1,307
+2% +$83.3K 0.84% 49
2018
Q2
$3.58M Buy
61,749
+1,176
+2% +$66.3K 0.75% 55
2018
Q1
$3.15M Buy
60,573
+2,846
+5% +$154K 0.69% 58
2017
Q4
$3.1M Buy
57,727
+1,153
+2% +$63.9K 0.66% 60
2017
Q3
$3.46M Buy
56,574
+2,071
+4% +$126K 0.79% 52
2017
Q2
$3.33M Buy
54,503
+275
+0.5% +$16.7K 0.79% 51
2017
Q1
$3.29M Buy
54,228
+1,768
+3% +$107K 0.8% 50
2016
Q4
$2.95M Buy
52,460
+4,021
+8% +$235K 0.76% 54
2016
Q3
$2.88M Buy
48,439
+1,155
+2% +$67.5K 0.78% 51
2016
Q2
$2.6M Sell
47,284
-296
-0.6% -$15.8K 0.74% 50
2016
Q1
$2.51M Buy
47,580
+4,427
+10% +$217K 0.73% 52
2015
Q4
$2.17M Buy
43,153
+11,428
+36% +$576K 0.67% 53
2015
Q3
$1.5M Buy
31,725
+9,063
+40% +$481K 0.49% 63
2015
Q2
$1.23M Hold
22,662
0.4% 68
2015
Q1
$1.24M Buy
22,662
+821
+4% +$46.5K 0.42% 65
2014
Q4
$1.18M Buy
21,841
+2,057
+10% +$115K 0.37% 70
2014
Q3
$1.12M Buy
19,784
+1,677
+9% +$94.2K 0.36% 71
2014
Q2
$1M Buy
18,107
+3,238
+22% +$177K 0.32% 79
2014
Q1
$805K Buy
14,869
+5,631
+61% +$292K 0.28% 84
2013
Q4
$441K Buy
9,238
+629
+7% +$28.8K 0.16% 104
2013
Q3
$391K Buy
+8,609
New +$393K 0.15% 106

Other funds holding MRK

Beese Fulmer Investment Management's MRK Position: Q1 2026 in Review

Beese Fulmer Investment Management reduced its Merck (MRK) stake by 8.7% in Q1 2026, selling an estimated $330K and leaving 30,114 shares worth $3.65M. The position accounts for 0.23% of the portfolio, ranked #79.

Beese Fulmer Investment Management first reported a position in MRK in Q3 2013 and has held it in 51 quarters since. The position peaked at $20.5M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Beese Fulmer Investment Management held 30,114 shares of Merck worth $3.65M as of Q1 2026.
  • Beese Fulmer Investment Management sold 2,862 Merck shares in Q1 2026, an estimated $330K.
  • Merck made up 0.23% of Beese Fulmer Investment Management's portfolio in Q1 2026, its #79 holding.
  • Beese Fulmer Investment Management first reported a position in Merck in Q3 2013 and has held it in 51 quarters since.
  • Beese Fulmer Investment Management's Merck position peaked at $20.5M in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Beese Fulmer Investment Management's 13F filing for Q1 2026, filed 16 Apr 2026.